Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56376 - 56400 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	MDFIC	29969	upregulated	panobinostat results in increased expression of MDFIC mRNA	7q31.1-q31.2	A21037
Panobinostat	Approved Investigational	ME3	10873	downregulated	panobinostat results in decreased expression of ME3 mRNA	11q14.2	A21037
Panobinostat	Approved Investigational	MECOM	2122	downregulated	panobinostat results in decreased expression of MECOM mRNA	3q26.2	A21037
Panobinostat	Approved Investigational	MED13L	23389	upregulated	panobinostat results in increased expression of MED13L mRNA	12q24.21	A21037
Panobinostat	Approved Investigational	MEF2C	4208	upregulated	panobinostat results in increased expression of MEF2C mRNA	5q14.3	A21037
Panobinostat	Approved Investigational	MEOX1	4222	upregulated	panobinostat results in increased expression of MEOX1 mRNA	17q21.31	A21037
Panobinostat	Approved Investigational	METRNL	284207	upregulated	panobinostat results in increased expression of METRNL mRNA	17q25.3	A21037
Panobinostat	Approved Investigational	MFAP3L	9848	downregulated	panobinostat results in decreased expression of MFAP3L mRNA	4q33	A21037
Panobinostat	Approved Investigational	MFNG	4242	downregulated	panobinostat results in decreased expression of MFNG mRNA	22q13.1	A21037
Panobinostat	Approved Investigational	MIA	8190	upregulated	panobinostat results in increased expression of MIA mRNA	19q13.2	A21037
Panobinostat	Approved Investigational	MIAT	440823	downregulated	panobinostat results in decreased expression of MIAT mRNA	22q12.1	A21037
Panobinostat	Approved Investigational	MICALCL	84953	upregulated	panobinostat results in increased expression of MICALCL mRNA	11p15.3	A21037
Panobinostat	Approved Investigational	MICALL1	85377	upregulated	panobinostat results in increased expression of MICALL1 mRNA	22q13.1	A21037
Panobinostat	Approved Investigational	MICB	4277	upregulated	panobinostat results in increased expression of MICB mRNA	6p21.33	A21037
Panobinostat	Approved Investigational	MID1IP1	58526	upregulated	panobinostat results in increased expression of MID1IP1 mRNA	Xp11.4	A21037
Panobinostat	Approved Investigational	MIR22HG	84981	upregulated	panobinostat results in increased expression of MIR22HG mRNA	17p13.3	A21037
Panobinostat	Approved Investigational	MMP14	4323	upregulated	panobinostat results in increased expression of MMP14 mRNA	14q11.2	A21037
Panobinostat	Approved Investigational	MNX1	3110	upregulated	panobinostat results in increased expression of MNX1 mRNA	7q36.3	A21037
Panobinostat	Approved Investigational	MPPED2	744	downregulated	panobinostat results in decreased expression of MPPED2 mRNA	11p14.1	A21037
Panobinostat	Approved Investigational	MPZ	4359	upregulated	panobinostat results in increased expression of MPZ mRNA	1q23.3	A21037
Panobinostat	Approved Investigational	MSX1	4487	upregulated	panobinostat results in increased expression of MSX1 mRNA	4p16.2	A21037
Panobinostat	Approved Investigational	MSX2	4488	upregulated	panobinostat results in increased expression of MSX2 mRNA	5q35.2	A21037
Panobinostat	Approved Investigational	MTHFD2L	441024	upregulated	panobinostat results in increased expression of MTHFD2L mRNA	4q13.3	A21037
Panobinostat	Approved Investigational	MUC15	143662	upregulated	panobinostat results in increased expression of MUC15 mRNA	11p14.3	A21037
Panobinostat	Approved Investigational	MUC4	4585	upregulated	panobinostat results in increased expression of MUC4 mRNA	3q29	A21037

Displaying entries 56376 - 56400 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability